2019
DOI: 10.1016/j.neuint.2019.104501
|View full text |Cite
|
Sign up to set email alerts
|

Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
9
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(12 citation statements)
references
References 47 publications
3
9
0
Order By: Relevance
“…To further confirm the antidiabetic effects of OEA in vivo, HFD/STZ diabetic rats were administered OEA for 6 weeks. Consistent with the effect of OEA on supressing plasma glucose in HFD/ STZ-induced mice (Ren et al, 2019), OEA treatment dosedependently decreased plasma glucose concentrations after 8-hour fasting in diabetic rats (Fig. 1A).…”
Section: Resultssupporting
confidence: 82%
See 4 more Smart Citations
“…To further confirm the antidiabetic effects of OEA in vivo, HFD/STZ diabetic rats were administered OEA for 6 weeks. Consistent with the effect of OEA on supressing plasma glucose in HFD/ STZ-induced mice (Ren et al, 2019), OEA treatment dosedependently decreased plasma glucose concentrations after 8-hour fasting in diabetic rats (Fig. 1A).…”
Section: Resultssupporting
confidence: 82%
“…OEA Ameliorated the HFD/STZ-Induced Hyperglycemia in a PPARa-Independent Manner. Our latest study indicated that OEA inhibited the elevation of plasma glucose in HFD/STZ-induced mice (Ren et al, 2019). To further confirm the antidiabetic effects of OEA in vivo, HFD/STZ diabetic rats were administered OEA for 6 weeks.…”
Section: Resultsmentioning
confidence: 98%
See 3 more Smart Citations